Methyl 7-bromo-2,3-dihydrobenzofuran-5-carboxylate

Catalog No.: 
ACHYQL384
CAS No.: 
2092670-06-7
Molecular Formula: 
C10H9BrO3
Molecular Weight: 
257.08
Methyl 7-bromo-2,3-dihydrobenzofuran-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$130.00In stockIn stock
5g98%$603.00In stockIn stock
25g98%$2925.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 7-bromo-2,3-dihydrobenzofuran-5-carboxylate
IUPAC Namemethyl 7-bromo-2,3-dihydrobenzofuran-5-carboxylate
MDL No.MFCD32905273
Molecular FormulaC10H9BrO3
Molecular Weight257.08
SMILESO=C(C1=CC(Br)=C(OCC2)C2=C1)OC
InChI KeyQIODYDLLNWOWAK-UHFFFAOYSA-N
Synonymmethyl 7-bromo-2,3-dihydrobenzofuran-5-carboxylate;methyl 7-bromo-2,3-dihydro-1-benzofuran-5-carboxylate;5-Benzofurancarboxylic acid, 7-bromo-2,3-dihydro-, methyl ester
CAS No.2092670-06-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHYQL384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRMEN875 route compound structure diagram
    ACRMEN875286836-79-1In Stock
  2. Then
  3. ACHYQL384 route product structure diagram
    ACHYQL3842092670-06-7In Stock
Inquiry

2. ACHYQL384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHYQL384 route product structure diagram
    ACHYQL3842092670-06-7In Stock
Inquiry

3. ACHYQL384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHYQL384 route product structure diagram
    ACHYQL3842092670-06-7In Stock
Inquiry

Comments (0)